FOR IMMEDIATE RELEASE Interdisciplinary Autoimmune Summit Successfully Launches First National Meeting for Co-management of IMID Patients Annual conference provides groundbreaking approaches to treating patients with... + read more
Thursday, July 17, 2014 - 09:28
Tuesday, July 15, 2014 - 10:30
Patients with inflammatory bowel disease on thiopurine therapy had an increased risk for lymphoma that abated after discontinuation of therapy, according to recent study data.
Tuesday, July 15, 2014 - 10:23
Pre-clinical studies show CEL-SCI's LEAPS technology prevented the development and lessened the severity of rheumatoid arthritis. CEL-SCI Corporation (NYSE MKT: CVM) announced today that it has been awarded a Phase I Small Business... + read more
Thursday, June 12, 2014 - 10:11
Researchers at Benaroya Research Institute at Virginia Mason (BRI) used cutting-edge tetramer technology developed at BRI to find the T cells that drive rheumatoid arthritis (RA). "By using tetramer technology, we were able to examine... + read more